Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick.
A gene coding for the Bm86 tick protein was recently cloned, expressed in Pichia pastoris and shown to induce an inmunological response in cattle against ticks. Moreover, the Gavac vaccine (Heber Biotec S.A., Havana, Cuba), which contains this recombinant protein, has proved to control the Boophilus microplus populations under field conditions. This paper reviews the development and large-scale production of this vaccine, the efficacy of the resulting product and the strategy followed in designing its production plant. The production plant fulfills biosafety requirements and GMP.
Canales
M
M
Division of Technological Development, Center for Genetic Engineering and Biotechnology, Havana, Cuba.
Enríquez
A
A
Ramos
E
E
Cabrera
D
D
Dandie
H
H
Soto
A
A
Falcón
V
V
Rodríguez
M
M
de la Fuente
J
J
D000818:Animals; D001709:Biotechnology / Q000379:methods; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000517:prevention & control; D005160:Facility Design and Construction; D005260:Female; D007115:Immunization Schedule; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000276:immunology*; D010843:Pichia / Q000276:immunology / Q000378:metabolism*; D011994:Recombinant Proteins; D013984:Tick Infestations / Q000517:prevention & control / Q000662:veterinary; D013987:Ticks / Q000276:immunology*; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000096:biosynthesis* / Q000276:immunology*
C085065:BM86 protein, Boophilus; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D014612:Vaccines; D014614:Vaccines, Synthetic